Abbott Laboratories and the French company Fournier have agreed to pay $22.5 million to 24 states - including Connecticut - to settle claims that the drug makers illegally blocked generic versions of the cholesterol-reducing drug TriCor. Connecticut will receive $224,714 from the agreement. A portion of the money will reimburse the state's Medicaid program for TriCor prescriptions it covered.
State Reaps $225K From Deal With Drug Makers
The Connecticut Law Tribune
January 25, 2010
This content is now available at LexisNexis®.
The ALM® and LexisNexis® Content Alliance
LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM’s legal news publications. LexisNexis® customers will be able to access and use ALM’s content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM’s other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.
ALM’s content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.
If you are not currently a LexisNexis subscriber, contact 1-800-227-4908 to find out more or click here to have a customer representative contact you directly.